MIOSTIN 0.5mg / ml injectible solution medication leaflet

N07AA01 neostigmine methyl sulfate • Nervous system | Parasympathomimetics | Anticholinesterases

Neostigmine methylsulfate is primarily used to reverse the effects of muscle relaxants used during surgery and to treat postoperative urinary retention. It works by inhibiting the enzyme acetylcholinesterase, increasing acetylcholine levels and stimulating muscle contractions.

The medication is usually administered via intravenous or intramuscular injection under the supervision of a specialist doctor. It is important to use it as directed to prevent adverse effects.

Side effects may include nausea, vomiting, abdominal cramps, diarrhea, excessive sweating, or bradycardia. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical intervention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as asthma or heart disease, as these may affect the safety of neostigmine methylsulfate use.

General data about MIOSTIN 0.5mg / ml

Substance: neostigmine methyl sulfate

Date of last drug list: 01-06-2025

Commercial code: W42889003

Concentration: 0.5mg / ml

Pharmaceutical form: injectible solution

Packing volume: 1 ml

Product type: generic

Price: 28.38 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ZENTIVA S.A. - ROMANIA

Holder: ZENTIVA S.A. - ROMANIA

Number: 6051/2005/01

Shelf life: 3 years

Other substances similar to neostigmine methyl sulfate

Combinations with other substances